Earnings Ahead

INBX - Inhibrx

25.24 0.34 1.37

Inhibrx

Inhibrx

About

Profile


Headquarters

La Jolla, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

INBX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Inhibrx GAAP EPS of -$0.90 beats by $0.04, revenue of $0.28M misses by $0.29M
  • Inhibrx stock soars 33% on potential accelerated approval path for INBRX-101 after FDA discussions
  • Inhibrx down 8% after announcing webcast for pathway for rare disease candidate
  • Europe drug regulator grants orphan designation to Inhibrx's drug for type of bone cancer
  • Inhibrx GAAP EPS of -$0.97 misses by $0.19, revenue of $0.71M misses by $0.36M
  • Inhibrx stock falls despite INBRX-101 showing safety in early-stage study in genetic disease
  • Inhibrx GAAP EPS of -$0.80 misses by $0.20, revenue of $0.93M misses by $0.17M
  • Inhibrx initiated as outperform at SMBC Nikko; sees 98% upside
  • Inhibrx's INBRX-101 for AAT deficiency gets FDA's orphan drug designation
  • Inhibrx GAAP EPS of -$0.55 beats by $0.02, revenue of $2.86M beats by $1.15M
  • Inhibrx falls after announcing resignation of medical chief
  • Inhibrx announces initial results from phase 1 trial of INBRX-106 in treating solid tumors
  • Inhibrx granted Orphan Drug designation for chondrosarcoma candidate
  • Inhibrx EPS beats by $0.03, beats on revenue
  • Inhibrx wins Street high target from Evercore after data for rare disease therapy
  • RRD, ATNX and NXTP among premarket gainers
  • Inhibrx gains 16% after INBRX-101 shows favorable safety profile in patients with AAT deficiency
  • Inhibrx EPS beats by $0.01, beats on revenue
  • Inhibrx initiates mid-stage INBRX-109 chondrosarcoma study
  • Inhibrx EPS beats by $0.08, misses on revenue

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 -0.54 / -0.57 2.53M / 1M Beat!
September 1, 2021 - / -0.555 - / 825K
August 9, 2021 -0.55 / -0.555 954K / 825K Beat!
May 13, 2021 -0.51 / -0.6125 889K / 925K
March 12, 2021 -0.47 / -0.5575 2.78M / 994K
November 13, 2020 -0.77 / -0.6033 5.9M / 1M Beat!
September 2, 2020 -0.675 / - 4.21M / - Beat!
Date Price Open High Low Vol Change ER
Aug 7, 2023 19.32 20.75
20.75
19.24
355K -6.21%
Aug 4, 2023 20.6 20.21
21.22
19.96
162K 2.18%
Aug 3, 2023 20.16 20.07
20.55
19.5
340K -0.44%
Aug 2, 2023 20.25 20.21
20.83
20.03
487K -1.32%
Aug 1, 2023 20.52 19.9
20.66
19.19
1.2M 2.34%
 
Jul 31, 2023 20.05 20.79
21.7
19.88
1.0M -3.56%
Jul 28, 2023 20.79 21.28
21.73
20.5
1.1M -0.81%
Jul 27, 2023 20.96 22.88
22.94
20.66
404K -7.5%
Jul 26, 2023 22.66 23.43
23.98
21.62
364K -3.25%
Jul 25, 2023 23.42 24.24
24.24
23.35
211K -3.54%
Jul 24, 2023 24.28 25.18
25.34
22.69
335K -3.54%
Jul 21, 2023 25.17 25.39
25.74
24.93
201K 0.08%
Jul 20, 2023 25.15 25.26
25.68
24.78
196K -0.79%
Jul 19, 2023 25.35 25.18
25.62
25.14
173K 0.92%
Jul 18, 2023 25.12 25.42
26.05
25.08
131K -1.02%
Jul 17, 2023 25.38 24.4
26.11
24.4
167K 4.40%
Jul 14, 2023 24.31 25.09
25.09
24.26
234K -3.11%
Jul 13, 2023 25.09 25.94
25.95
25.02
119K -2.83%
Jul 12, 2023 25.82 25.43
26.1
24.97
236K 3.69%
Jul 11, 2023 24.9 25.54
25.88
24.9
167K -2.81%
Jul 10, 2023 25.62 23.89
25.83
23.89
271K 6.62%
Jul 7, 2023 24.03 25.07
25.34
23.89
170K -3.88%
Jul 6, 2023 25 25.01
25.16
24.31
249K -1.73%
Jul 5, 2023 25.44 26.31
26.34
24.98
216K -3.31%
Jul 3, 2023 26.31 26.03
26.77
25.62
177K 1.35%
Jun 30, 2023 25.96 25.94
26.3
25.45
297K 0.89%
Jun 29, 2023 25.73 26.03
26.38
25.55
290K -1%
Jun 28, 2023 25.99 25.4
26.02
25.1
184K 2.97%
Jun 27, 2023 25.24 25.04
25.52
24.63
175K 1.37%
Jun 26, 2023 24.9 25.99
26.16
24.73
233K -5.03%
Jun 23, 2023 26.22 26.38
26.71
25.38
720K -1.54%
Jun 22, 2023 26.63 26.88
27.74
26.36
204K -0.82%
Jun 21, 2023 26.85 27.02
27.11
26.17
178K -1.18%
Jun 20, 2023 27.17 26
27.35
25.39
358K 3.70%
Jun 16, 2023 26.2 28.33
28.33
26.01
895K -5.82%
Jun 15, 2023 27.82 26.82
28.7
26.49
329K 3.46%
Jun 14, 2023 26.89 27.63
28.28
26.1
238K -2.29%
Jun 13, 2023 27.52 25.26
28
25.26
409K 8.22%
Jun 12, 2023 25.43 23.64
25.47
23.5
548K 8.72%
Jun 9, 2023 23.39 24.75
24.75
23.18
291K -4.8%
Jun 8, 2023 24.57 24.64
24.84
23.67
656K -0.36%
Jun 7, 2023 24.66 24.45
25.26
23.74
360K 0.69%
Jun 6, 2023 24.49 24.2
24.72
23.84
185K 1.87%
Jun 5, 2023 24.04 24.37
24.89
23.38
198K -2.28%
Jun 2, 2023 24.6 24.49
24.65
23.2
228K 1.61%
Jun 1, 2023 24.21 23.79
25.21
23.24
312K 2.32%
May 31, 2023 23.66 23.6
24.76
23.24
293K 0.64%
May 30, 2023 23.51 24.14
24.61
22.74
334K -2.69%
May 26, 2023 24.16 23.05
24.38
22.6
422K 4.91%
May 25, 2023 23.03 23.47
23.47
22.14
319K -1.41%
May 24, 2023 23.36 22.75
23.54
22.33
337K 1.65%
May 23, 2023 22.98 24.71
25.14
22.97
341K -6.89%
May 22, 2023 24.68 25
26.45
24.37
312K -1.91%
May 19, 2023 25.16 24.72
25.23
24.54
168K 3.62%
May 18, 2023 24.28 24.39
24.79
23.47
299K -1.06%
May 17, 2023 24.54 24.83
25.62
23.92
257K -0.85%
May 16, 2023 24.75 24.35
25.38
23.2
448K -1.59%
May 15, 2023 25.15 24.96
26.21
24.18
316K 1.70%
May 12, 2023 24.73 25.07
25.56
24.34
190K -1.36%
May 11, 2023 25.07 25.63
26.5
24.33
443K 0%